Your session is about to expire
← Back to Search
VIB4920 for Sjögren's Syndrome (SS Trial)
SS Trial Summary
This trial is to study a new drug for Sjögren's Syndrome to see if it is effective, safe, and tolerated.
- Sjögren's Syndrome
SS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2023 Phase 2 trial • 25 Patients • NCT04046549SS Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has recruitment for this experiment already begun?
"As per clinicaltrials.gov, this medical trial has stopped recruiting participants at this time; the study was initially posted on October 16th 2019 and most recently revised September 9th 2022. Although there are no recruitment activities for this investigation presently, 1386 other trials require volunteers right now."
What potential risks have been associated with the use of VIB4920?
"The safety of VIB4920 has been rated a 2. This is because Phase 2 trials indicate that while there are some data points in favor of its security, efficacy remains untested."
Is the subject pool for this trial inclusive of participants over sixty years in age?
"To abide by this trial's inclusion standards, the lowest eligible age for enrollment is 18 and there exists an upper bound of 75."
In what quantity of health care facilities is this trial currently underway?
"The trial is currently recruiting from 15 locations across the USA, such as Houston, Lawrenceville and Wheaton. To reduce travel commitments during the study, participants are encouraged to select a centre that is closest to them for enrolment."
Who is able to qualify for inclusion in this clinical trial?
"This clinical trial requires that participants suffer from sjögren's syndrome and be between 18-75 years old. Accommodating 183 patients, this study is open for enrollment."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger